Description

Clostridium difficile infection rates among ICU patients in the probiotic intervention group versus controls are tracked, assessing the preventive potential of Lactobacillus casei.

Figure 3

Chart

Source Paper

Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.

Nutrients (2018)

PMID: 29701662

DOI: 10.3390/nu10050539

Cite This Figure

![Figure 3: Clostridium difficile infection rates among ICU patients in the probiotic intervention group versus controls are tracked, assessing the preventive potential of Lactobacillus casei.]()

> Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." *Nutrients*, 2018. PMID: [29701662](https://pubmed.ncbi.nlm.nih.gov/29701662/)

<figure>
  <img src="" alt="Clostridium difficile infection rates among ICU patients in the probiotic intervention group versus controls are tracked, assessing the preventive potential of Lactobacillus casei." />
  <figcaption>Figure 3. Clostridium difficile infection rates among ICU patients in the probiotic intervention group versus controls are tracked, assessing the preventive potential of Lactobacillus casei.<br>  Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29701662/">29701662</a></figcaption>
</figure>

Related Evidence

Lactobacillus casei for Antibiotic-Associated Diarrhea (AAD)

Grade C · 3 studies